-+ 0.00%
-+ 0.00%
-+ 0.00%
Teva's application for the new Ecopipam drug received priority review by the US FDA.
Share
Listen to the news
Teva's application for the new Ecopipam drug received priority review by the US FDA.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending